Aurobindo Acquires Four Biosimilars, Including Avastin Biosimilar Molecule
By
Aurobindo Pharma, a Hyderabad, India-headquartered generics and active pharmaceutical ingredients manufacturer, has acquired four cell-culture-derived biosimilar candidates from TL Biopharmaceutical AG, based in Switzerland. Three of the four candidates are…